Thoroughbred Financial Services, LLC Gilead Sciences, Inc. Transaction History

Thoroughbred Financial Services, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $196,363 - $222,681	2,680 New	2,680 $217,000
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $180,524 - $226,978	-2,907 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $44,633 - $51,828	-617 Reduced 17.51%	2,907 $224,000
Q1 2020 Apr 23, 2020	BUY	$62.63 - $80.22 $26,054 - $33,371	416 Added 13.38%	3,524 $263,000
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $192,932 - $212,219	-3,131 Reduced 50.18%	3,108 $202,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $40,131 - $44,298	-642 Reduced 9.33%	6,239 $395,000
Q2 2019 Jul 16, 2019	SELL	$61.87 - $69.38 $28.3 Million - $31.8 Million	-458,018 Reduced 98.52%	6,881 $0
Q2 2019 Jul 16, 2019	BUY	$61.87 - $69.38 $28 Million - $31.4 Million	452,256 Added 3577.13%	464,899 $0
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $9,004 - $10,087	-144 Reduced 1.13%	12,643 $822,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $774,124 - $1.01 Million	12,787 New	12,787 $799,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.